These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 31232860)

  • 1. Current market trends in anterior ocular inflammatory disease landscape.
    Khan RS; Rizvi S; Syed BA; Bielory L
    Curr Opin Allergy Clin Immunol; 2019 Oct; 19(5):503-509. PubMed ID: 31232860
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacoeconomics of anterior ocular inflammatory disease.
    Bielory L; Syed BA
    Curr Opin Allergy Clin Immunol; 2013 Oct; 13(5):537-42. PubMed ID: 23945174
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Current options and emerging therapies for anterior ocular inflammatory disease.
    Syed BA; Kumar S; Bielory L
    Curr Opin Allergy Clin Immunol; 2014 Oct; 14(5):485-9. PubMed ID: 25102104
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recent Patents and Emerging Therapeutics on Ocular Inflammation and Allergy.
    Agrahari V; Aulgur Z; Thukral S; Dhall N; Conley R; Mitra AK
    Recent Pat Inflamm Allergy Drug Discov; 2017; 11(2):92-106. PubMed ID: 28901856
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chemokines in allergic conjunctivitis.
    Erdinest N; London N; Solomon A
    Curr Opin Allergy Clin Immunol; 2020 Oct; 20(5):516-527. PubMed ID: 32739979
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Future directions in therapeutic interventions for conjunctival inflammatory disorders.
    Pflugfelder SC; Stern ME
    Curr Opin Allergy Clin Immunol; 2007 Oct; 7(5):450-3. PubMed ID: 17873588
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of the effects of olopatadine ophthalmic solution, 0.2% on the ocular surface of patients with allergic conjunctivitis and dry eye.
    Mah FS; O'Brien T; Kim T; Torkildsen G
    Curr Med Res Opin; 2008 Feb; 24(2):441-7. PubMed ID: 18167176
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Advances in ocular allergy: basic mechanisms, clinical patterns and new therapies.
    Solomon A; Pe'er J; Levi-Schaffer F
    Curr Opin Allergy Clin Immunol; 2001 Oct; 1(5):477-82. PubMed ID: 11964730
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [New aspects in drug therapy of ocular allergies].
    Maĭchuk IuF
    Vestn Oftalmol; 2000; 116(5):10-4. PubMed ID: 11221368
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Flavonoid and cannabinoid impact on the ocular surface.
    Bielory L; Tabliago NRA
    Curr Opin Allergy Clin Immunol; 2020 Oct; 20(5):482-492. PubMed ID: 32796166
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Allergic conjunctivitis: the evolution of therapeutic options.
    Bielory L
    Allergy Asthma Proc; 2012; 33(2):129-39. PubMed ID: 22525389
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The anti-inflammatory effects of therapies for ocular allergy.
    Mantelli F; Calder VL; Bonini S
    J Ocul Pharmacol Ther; 2013 Nov; 29(9):786-93. PubMed ID: 24044620
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of ocular inflammatory conditions with loteprednol etabonate.
    Pavesio CE; Decory HH
    Br J Ophthalmol; 2008 Apr; 92(4):455-9. PubMed ID: 18245274
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Treatment of conjunctivitis].
    Barabási Z
    Orv Hetil; 2004 Oct; 145(41):2107-10. PubMed ID: 15586586
    [No Abstract]   [Full Text] [Related]  

  • 15. Time to manage seasonal ocular allergies.
    Smith SE
    J Ophthalmic Nurs Technol; 2000; 19(2):68-73. PubMed ID: 11075076
    [No Abstract]   [Full Text] [Related]  

  • 16. Advances in pharmacotherapy for allergic conjunctivitis.
    Abelson MB; Shetty S; Korchak M; Butrus SI; Smith LM
    Expert Opin Pharmacother; 2015 Jun; 16(8):1219-31. PubMed ID: 25943976
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ocular surface disease: a case of vernal keratoconjunctivitis.
    Chigbu DI; Sandrasekaramudaly-Brown S
    Cont Lens Anterior Eye; 2011 Feb; 34(1):39-44. PubMed ID: 20971677
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Current and Future Pharmacological Therapies for the Management of Dry Eye.
    Gupta PK; Asbell P; Sheppard J
    Eye Contact Lens; 2020 Mar; 46 Suppl 2():S64-S69. PubMed ID: 31625981
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Allergic complications with laser-assisted in-situ keratomileusis.
    Bielory BP; O'Brien TP
    Curr Opin Allergy Clin Immunol; 2011 Oct; 11(5):483-91. PubMed ID: 21822133
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ocular allergic disorders and dry eye disease: associations, diagnostic dilemmas, and management.
    Berdy GJ; Hedqvist B
    Acta Ophthalmol Scand Suppl; 2000; (230):32-7. PubMed ID: 11057347
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.